Kangji Medical, Knight Bidco release privatisation scheme circular

The Independent Board Committee deems the proposal to be fair and reasonable.

Kangji Medical Holdings Limited and Knight Bidco Limited have jointly dispatched a circular detailing the proposed privatisation of Kangji Medical via a scheme of arrangement.

The proposal offers Scheme Shareholders a definitive opportunity to realise their investment amidst market volatility and uncertainty.

The Independent Board Committee (IBC), relying on advice from the Independent Financial Adviser, deems the proposal, the scheme, and the special deal to be fair and reasonable to Independent Shareholders.

The meeting is scheduled for 10 November, followed by the Extraordinary General Meeting. Shareholders are urged to review the scheme document before making a decision.

Upon completion, Kangji Medical will become a wholly-owned subsidiary of Knight Bidco, and its listing on the Stock Exchange will be withdrawn.

Kangji Medical is a Hangzhou-based medical device group specialising in minimally invasive surgery instruments and accessories.

Meanwhile, Knight Bidco is an investment holding company formed by a consortium including Fortune Spring ZM, Fortune Spring YG, TPG Asia VII, Keyhole, Knight Success, NewQuest V, and Al-Rayyan Holding.